Followers | 118 |
Posts | 15266 |
Boards Moderated | 0 |
Alias Born | 08/31/2006 |
Thursday, May 06, 2021 10:52:06 AM
Recent XERS News
- Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference • Business Wire • 11/26/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2024 09:02:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 12:13:35 PM
- Xeris Biopharma Reports Third Quarter 2024 Financial Results • Business Wire • 11/08/2024 12:00:00 PM
- Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024 • Business Wire • 10/31/2024 12:00:00 PM
- Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 10/04/2024 08:05:00 PM
- Xeris to Participate in Upcoming Investor Conferences • Business Wire • 08/22/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 08:06:56 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/08/2024 08:27:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:15:47 AM
- Xeris Biopharma Reports Second Quarter 2024 Financial Results • Business Wire • 08/08/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 09:22:39 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 09:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 08:14:16 PM
- Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024 • Business Wire • 07/25/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 11:14:32 AM
- Xeris Biopharma Announces CEO Succession Plan • Business Wire • 07/08/2024 11:00:00 AM
- Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 07/03/2024 05:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:19:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:15:27 PM
- Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024 • Business Wire • 06/03/2024 11:00:00 AM
- Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121) • Business Wire • 05/30/2024 11:30:00 AM
- Xeris to Participate in the Jefferies Global Healthcare Conference • Business Wire • 05/30/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:14:33 AM
- Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events • Business Wire • 05/09/2024 11:00:00 AM
FEATURED Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM
UAV Corp. (UMAV) Reduces Authorized Shares by 1.2 Billion, Demonstrating Commitment to Shareholders; New Authorized Share Count Approved at 800 Million • UMAV • Dec 17, 2024 12:00 PM